<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(12)</volume><submitter>Haddock NT</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Breast reconstruction after mastectomy improves quality of life for breast cancer patients. As more late-stage patients undergo reconstruction, it is essential to understand how treatment regimens and radiation impact outcomes. This study compared early- and late-stage breast cancer patients, examining comorbidities, reconstructive details, complications, and satisfaction.&lt;h4>Methods&lt;/h4>A total of 989 patients (903 early-stage; 86 late-stage) who underwent breast reconstruction between January 2011 and February 2025 were reviewed. Cancer staging followed the National Cancer Institute definitions: early-stage (I-IIIA) and late-stage (IIIB-IV).&lt;h4>Results&lt;/h4>Late-stage patients had higher rates of diabetes (&lt;i>P&lt;/i> = 0.003), neoadjuvant chemotherapy (&lt;i>P&lt;/i> &lt; 0.001), </pubmed_abstract><journal>Plastic and reconstructive surgery. Global open</journal><pagination>e7361</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12711366</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Exploring Breast Reconstruction in Late-stage Breast Cancer Patients.</pubmed_title><pmcid>PMC12711366</pmcid><pubmed_authors>Haddock NT</pubmed_authors><pubmed_authors>Troia TC</pubmed_authors><pubmed_authors>Teotia SS</pubmed_authors><pubmed_authors>Kim LJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Exploring Breast Reconstruction in Late-stage Breast Cancer Patients.</name><description>&lt;h4>Background&lt;/h4>Breast reconstruction after mastectomy improves quality of life for breast cancer patients. As more late-stage patients undergo reconstruction, it is essential to understand how treatment regimens and radiation impact outcomes. This study compared early- and late-stage breast cancer patients, examining comorbidities, reconstructive details, complications, and satisfaction.&lt;h4>Methods&lt;/h4>A total of 989 patients (903 early-stage; 86 late-stage) who underwent breast reconstruction between January 2011 and February 2025 were reviewed. Cancer staging followed the National Cancer Institute definitions: early-stage (I-IIIA) and late-stage (IIIB-IV).&lt;h4>Results&lt;/h4>Late-stage patients had higher rates of diabetes (&lt;i>P&lt;/i> = 0.003), neoadjuvant chemotherapy (&lt;i>P&lt;/i> &lt; 0.001), </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-06-07T05:26:20.374Z</modification><creation>2026-06-07T03:07:13.257Z</creation></dates><accession>S-EPMC12711366</accession><cross_references><pubmed>41415597</pubmed><doi>10.1097/GOX.0000000000007361</doi></cross_references></HashMap>